DUBLIN--(BUSINESS WIRE)--Oct 10, 2018--Horizon Pharma plc (Nasdaq: HZNP) announced today that its third-quarter financial results will be released on Wednesday, Nov. 7, 2018. Following the announcement, Horizon’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results.
The live webcast and replay may be accessed at http://ir.horizon-pharma.com. Please connect to the Company’s website at least 15 minutes before the live webcast to ensure adequate time for any software download that may be needed to access the webcast.
About Horizon Pharma plc
Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases. By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians. For us, it’s personal: by living up to our own potential, we are helping others live up to theirs. For more information, please visit www.horizonpharma.com, follow us @HZNPplc on Twitter, like us on Facebook or explore career opportunities on LinkedIn.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181010005122/en/
CONTACT: Horizon Pharma plc
Senior Vice President,
Executive Vice President,
Corporate Affairs & Chief Communications Officer
KEYWORD: UNITED STATES EUROPE NORTH AMERICA NEW YORK IRELAND
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL OTHER HEALTH RESEARCH SCIENCE GENERAL HEALTH
SOURCE: Horizon Pharma plc
Copyright Business Wire 2018.
PUB: 10/10/2018 08:00 AM/DISC: 10/10/2018 08:01 AM